DILANTIN TOXICITY - MILIARY PULMONARY INFILTRATES AND HYPOXEMIA

被引:27
作者
BAYER, AS
TARGAN, SR
PITCHON, HE
GUZE, LB
机构
[1] HARBOR GEN HOSP, TORRANCE, CA 90509 USA
[2] UNIV CALIF LOS ANGELES, MED CTR, LOS ANGELES, CA 90509 USA
[3] VET ADM WADSWORTH HOSP CTR, LOS ANGELES, CA 90073 USA
关键词
D O I
10.7326/0003-4819-85-4-475
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:475 / 476
页数:2
相关论文
共 6 条
  • [1] PULMONARY-FUNCTION LOSS IN DIPHENYLHYDANTOIN THERAPY
    HAZLETT, DR
    WARD, GW
    MADISON, DS
    [J]. CHEST, 1974, 66 (06) : 660 - 664
  • [2] THE LACK OF PULMONARY FIBROSIS IN PATIENTS RECEIVING DIPHENYLHYDANTOIN
    LOW, NL
    YAHR, MD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1960, 174 (09): : 1201 - 1202
  • [3] PULMONARY CHANGES IN HYDANTOIN THERAPY
    MOORE, MT
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1959, 171 (10): : 1328 - 1333
  • [4] SALTZSTEIN SL, 1959, CANCER-AM CANCER SOC, V12, P164, DOI 10.1002/1097-0142(195901/02)12:1<164::AID-CNCR2820120122>3.0.CO
  • [5] 2-Y
  • [6] DIAGNOSTICALLY CONFUSING COMPLICATIONS OF DIPHENYLHYDANTOIN THERAPY
    SPARBERG, M
    [J]. ANNALS OF INTERNAL MEDICINE, 1963, 59 (06) : 914 - +